Sanofi Switch Gives UK Hay Fever Sufferers Additional Mass Market Option
Executive Summary
Sanofi has switched its Allevia hay fever tablets (fexofenadine hydrochloride) in the UK, from prescription-only to general sales list status.
You may also be interested in...
Dr Reddy’s Grows Consumer Health Offering In UK And US
Through a UK product launch and US acquisition, generics player Dr Reddy’s is stepping up its interest in the consumer health market.
Dr Reddy's Grows Consumer Health Offering In UK And US
Through a UK product launch and US acquisition, generics player Dr Reddy's is stepping up its interest in the consumer health market.
Sanofi Pulls Allevia 'Non-Drowsy' Claim Following MHRA Probe
Sanofi's claim in a TV ad that its Allevia hay fever tablets were non drowsy contradicted the drug's summary of product characteristics, found an investigation by the UK's Medicines and Healthcare products Regulatory Agency.